Lorenz, Inga
Bodschwinna, Daniela
Hallensleben, Nina
Döhner, Hartmut
Niederwieser, Dietger
Zimmermann, Tanja
Mehnert, Anja
Gündel, Harald
Ernst, Jochen
Hoenig, Klaus
Funding for this research was provided by:
José Carreras Leukämie-Stiftung (DJCLS 23R/2016, DJCLS 23R/2016)
Article History
Received: 31 March 2019
Accepted: 26 August 2019
First Online: 5 September 2019
Ethics approval and consent to participate
: Ethics approval (No. 373/16-ek) has been obtained for the INPART study from the ethics committee of the medical faculty of the University of Leipzig. Written informed consent or assent will be obtained from potential eligible participants (patients and partners) in the INPART study using standardized effectual forms issued from the local ethics committee.
: Not applicable.
: The authors declare that they have no competing interests.